THURSDAY, Dec. 6 (HealthDay News) -- Taking a patient's weight
into account when choosing blood pressure medications might help
prevent strokes, heart attacks and death, a new study suggests.
Lean and obese people react differently to different blood
pressure medications, said the researchers, who believe their
findings could change the way high blood pressure (hypertension) is
"Unexpectedly, people who have high blood pressure and are fat actually have a better prognosis than people who have high blood pressure and are thin," said lead researcher Dr. Michael Weber, a professor of medicine at Downstate Medical Center of the State University of New York in New York City.
"You can now choose blood pressure medication as a means of compensating for this difference between obese and thin people, so that it's possible to treat everybody with a medicine that maximizes the outcome regardless of how much you weigh," he said.
Weber recommends starting all patients with high blood pressure
on a class of drugs called calcium channel blockers, regardless of
weight. One such drug is Norvasc (amlodipine).
Although diuretics, which reduce excess water in the body, are
effective in obese patients, they can harm thin patients, and
should be relegated to a third-line therapy, Weber said.
Obese people respond better to diuretics, Weber explained,
because their hypertension is often caused by a combination of
excess weight, too much fluid and too much salt. Thin hypertensive
patients, he said, may have underlying circulatory problems that
are causing their high blood pressure and placing them at increased
risk for cardiovascular disease.
For the study, published in the Dec. 6 online edition of
The Lancet, Weber's group analyzed data on more than 11,000
individuals in an international high blood pressure trial.
That trial compared treatment with a diuretic and Lotensin
(benazepril), which is known as an ACE inhibitor, with a regimen of
Lotensin plus the calcium channel blocker Norvasc.
The goal of the study was to see which combination better
controlled high blood pressure in people at high risk for heart
disease and to see if weight had an effect on blood pressure
Participants were grouped into three categories -- normal
weight, overweight and obese -- based on their body mass index
(BMI). BMI is a body fat calculation based on height and
Normal-weight people taking the diuretic fared the worst, the
investigators found. This group was 68 percent more likely to have
a heart attack, stroke or die than obese patients taking a
People taking the Lotensin-Norvasc combination did well
regardless of weight, they found. This drug duo reduced stroke,
heart attack and death by 43 percent in normal-weight people and 24
percent in overweight people, according to the study.
Among obese people, both drug regimens worked well with no
significant differences between them, the researchers found.
However, some doctors argue against giving obese patients
"We disagree that diuretics are a reasonable choice for the obese patient," said Dr. Franz Messerli, a cardiologist and director of the hypertension program at St. Luke's-Roosevelt Hospital and Columbia University College of Physicians and Surgeons in New York City.
Obesity is a reason
notto use diuretics, he said. Diuretics should be used only
when certain types of heart disease, including heart failure,
exist, said Messerli, co-author of an accompanying journal
In obese patients, diuretics can trigger poor blood sugar
control and gout, Messerli said.
Messerli agreed that calcium channel blockers should be
first-line treatment for all patients with high blood pressure
whether they are fat, thin or in between.
Dr. Gregg Fonarow, a spokesman for the American Heart
Association and a professor of cardiology at the University of
California, Los Angeles, said the study findings may be an example
of the "obesity paradox." This theory holds that obesity is a
well-established risk factor for developing hypertension, heart
disease and heart failure, while "among individuals with
established hypertension, coronary heart disease, and heart
failure, obesity has been unexpectedly associated with lower
cardiovascular event rates and mortality."
These new findings suggest that an individual's BMI should be
considered when selecting anti-hypertensive medications, he
"Treatment with calcium channel blockers appears preferable to treatment with diuretics in non-obese men and women with hypertension," Fonarow said.
The study was funded by Novartis Pharmaceuticals, maker of
For more information on high blood pressure, visit the
American Heart Association.
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Information Services. All rights reserved.